Stock listing
OTC:BPMUF Basilea Pharmaceutica AG Stock
US listing (OTC) of Basilea Pharmaceutica AG · home listing SIX Swiss:BSLN
Follow Basilea Pharmaceutica AG into a list and get an email when it puts out news.
Share price · OTC:BPMUF
$84.00 USD +7.75 (+10.2%)
Close on Nov 11, 2026
- Day range
- $84.00 – $84.00 USDNov 11, 2026
- Volume
- 10 sharesNov 11, 2026
- Market cap
- $1.04B USDAt the close on Nov 11, 2026 · price × 12.39M shares outstanding
- 52-week range
- $59.29 – $84.00 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
- Traded on an average day
- $858 USDMedian day 0 shares · 56 days with no trades · last 3 months, Aug 11, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BSLN · Home | 71.50 CHF | -0.40 (-0.6%) | 23,748 | 71.80 | 73.00 | 71.30 | 71.90 | Close on Nov 18, 2026 |
| LSE:0QNA | 71.30 CHF | -0.70 (-1.0%) | 2,104 | 72.75 | 72.75 | 71.30 | 72.00 | Close on Nov 18, 2026 |
| OTC:BPMUF | $84.00 USD | +7.75 (+10.2%) | 10 | $84.00 | $84.00 | $84.00 | $76.25 | Close on Nov 11, 2026 |
Daily closes
Last 3 months, Aug 11, 2026 – Nov 6, 2026 · OTC:BPMUF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | 0.00 | 0.0% | $76.25 | $76.25 | $76.25 | 0 | |
| $76.25 | -1.15 | -1.5% | $76.25 | $76.25 | $76.25 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 100 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | 0.00 | 0.0% | $77.40 | $77.40 | $77.40 | 0 | |
| $77.40 | +11.90 | +18.2% | $77.40 | $77.40 | $77.40 | 100 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 | |
| $65.50 | 0.00 | 0.0% | $65.50 | $65.50 | $65.50 | 0 |
- Ticker
- OTC:BPMUF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Latest earnings call · Aug 18, 2026
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 42 slides
Calls
Replays
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Tue, Aug 18, 2026 · 10:00 AM ET
Watch Transcript
Latest news
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Oct 27, 2026
Closed $76.25 (0.0%) on Oct 27, 2026
Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026
Oct 20, 2026
Closed $76.25 (0.0%) on Oct 20, 2026
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
Sep 14, 2026
Closed $77.40 (0.0%) on Sep 14, 2026
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
Aug 18, 2026
Closed $65.50 (0.0%) on Aug 18, 2026
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Aug 5, 2026
Closed $64.70 (0.0%) on Aug 5, 2026
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
Jul 29, 2026
Closed $60.28 (0.0%) on Jul 29, 2026
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
Closed $65.10 (0.0%) on May 28, 2026
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Apr 15, 2026
Closed $69.56 (-2.0%) on Apr 15, 2026
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Apr 9, 2026
Closed $71.00 (0.0%) on Apr 9, 2026
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Mar 23, 2026
Closed $71.00 (0.0%) on Mar 23, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 42 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 43 slides · Oct 1, 2026
H1 2026 Earnings Presentation
Earnings · 70 slides · Aug 18, 2026
H1 2026 Earnings Presentation
Earnings · 29 slides · Aug 18, 2026
Basilea Pharmaceutica AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 19 in the last 12 months · 32 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 18, 2026
- Decks
- 5 decks · latest Oct 27, 2026
Where Basilea Pharmaceutica AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BSLN · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QNA | LSE | United Kingdom | CHF |
| gettex:PK5 | gettex | Germany | EUR |
| Aquis:BSLNZ | Aquis | United Kingdom | CHF |
| OTC:BPMUF · This page | OTC | United States | USD |
| Lang & Schwarz:A0B9GA | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0B9GA | LS Exchange | Germany | EUR |
| Tradegate:PK5 | Tradegate | Germany | EUR |
| BX Swiss:PK5 | BX Swiss | Switzerland | CHF |
| Munich:PK5 | Munich | Germany | EUR |
| Turquoise:BSLNZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:PK5 | Dusseldorf | Germany | EUR |
| Frankfurt:PK5 | Frankfurt | Germany | EUR |
| Hamburg:PK5 | Hamburg | Germany | EUR |
| Stuttgart:PK5 | Stuttgart | Germany | EUR |
| Hanover:PK5 | Hanover | Germany | EUR |
| Xetra:PK5 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Basilea Pharmaceutica AG.